RT Journal Article
SR Electronic
T1 18F-DCFPyL PET/CT in Metastatic Renal Cell Carcinoma
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP jnmt.121.262799
DO 10.2967/jnmt.121.262799
A1 Geoffrey M Currie
A1 Marko Trifunovic
A1 Jui Liu
A1 Sang Kim
A1 Howard Gurney
YR 2021
UL http://tech.snmjournals.org/content/early/2021/11/08/jnmt.121.262799.abstract
AB Targeted molecular imaging with positron emission tomography (PET) utilize chemical ligands is a peptide that specifically targets a receptor of interest. Prostate specific membrane antigen (PSMA) is substantially upregulated in prostate cancer but is also expressed in the neovascular tissue of several malignancies, including renal cell carcinoma (RCC). Radiolabeled peptide targets for PSMA may be helpful in detecting metastatic RCC lesions. This teaching case provides an insight incidental detection of RCC metastatic disease with PSMA targeted PET and explores potential in deliberate evaluation of RCC with PSMA targeted tracers.